Chantale Bernatchez

Chantale Bernatchez

Company: MD Anderson Cancer Center

Job title: Associate Director, Biologics Development


My main interest is immunotherapy of cancer with a special emphasis on T cell therapy utilizing tumor infiltrating lymphocytes. My lab conducts translational research where human primary cells from cancer patients (tumors or immune cells) are interrogated to find markers of response to T cell therapy or other immunotherapies. Another focus of my research is towards process development in order to streamline the complex and time consuming method to expand the T cells ex-vivo. We are hoping to develop an easier and more cost effective T cell manufacturing process in collaboration with the industry with the aim to make commercialization of TIL a viable path. We owe to our patients to optimize ways to disseminate this treatment to the masses of patients needing it.


Live Q&A with Your Expert Speakers 3:00 pm

Use this opportunity to ask your expert speakers those burning questionsRead more

day: Day Two

Infusing Optimal TILs 2:35 pm

Functional improvements of TIL through the use of agonistic 41BB stimulation Genetic engineering of TGF-β dominant negative receptor in TIL for the treatment of metastatic melanomaRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.